Altered ethanolamine plasmalogen and phosphatidylethanolamine levels in blood plasma of patients with bipolar disorder.
Shintaro OgawaKotaro HattoriMiho OtaShinsuke HideseTomoko MiyakawaRyo MatsumuraYuuki YokotaIkki IshidaJunko MatsuoSumiko YoshidaYasuyo YamazakiDayan GoodenoweHiroshi KunugiPublished in: Psychiatry and clinical neurosciences (2020)
Plasma PLE and PTE levels were associated with BP I, but not with BP II. Moreover, plasma PTE levels differed between patients with BP I and II. Our findings highlight the importance of ethanolamine phospholipids in the pathophysiology of BP, especially BP I.